Stray alert on Quantum BioPharma withdrawn

QNTM•2026-09-14

Alert withdrawn

An alert from NetworkNewsAudio announcing an audio press release about FDA clearance of a clinical trial involving Quantum BioPharma was inadvertently published and has been withdrawn.

There will be no substitute.

Stray alert on Quantum BioPharma withdrawn

Alert withdrawn

Related News

Ernexa Therapeutics CEO Sanjeev Luther presents at H.C. Wainwright Global Investment Conference

Sanofi transfers 20 mature drugs, three plants to Cheplapharm for 26.4% stake

BofA Global Research Sets 12-Month Target for S&P 500 Index at 7800

TransDigm launches cash tender offer for any and all 6.75% senior secured notes due 2028 at USD 1,008 per USD 1,000 early-tendered

Avient to showcase simulation-ready composite material cards at CAMX 2026